Portfolio Adjustments
Heartland Advisors Executes Portfolio Adjustments, Trimming Some Stakes While Increasing Others
Key Points
Heartland Advisors’ Exelon trim is described with specific share activity: it held 401,724 shares after selling 29,340 shares, with the stake valued at about $17.51 million (Exelon was 0.9% of the portfolio).
Several other institutional investors increased Exelon positions notably, including Nordea Investment Management AB (up 14.6% to 8,048,355 shares) and ASR Vermogensbeheer N.V. (up 28.4% to 272,233 shares), underscoring that the selling pressure was not uniform across holders.
For Sensient Technologies, the article adds an insider transaction detail: VP Thierry Hoang sold 439 shares at an average price of $114.15 for about $50,111.85, according to the cited news item alongside Heartland’s 7.3% trim.
On Columbus McKinnon, the report highlights how other funds also substantially increased exposure—for example, Marshall Wace LLP up 698.6% (to 726,772 shares) and Hotchkis & Wiley Capital Management LLC up 100.2% (to 829,875 shares)—while institutional investors own 95.96% of the stock.
For NOV, the piece includes analyst context in addition to Heartland’s 3.2% reduction: Stifel Nicolaus raised its NOV price target from $21.00 to $23.00 and reiterated a “buy” rating (as cited in the article).
Heartland Advisors trimmed its Exelon stake by 6.8% in the fourth quarter, selling 29,340 shares and leaving the Milwaukee-based value fund holding 401,724 shares worth about $17.51 million, according to Watchlist News. The Exelon position now makes up just 0.9% of Heartland's total portfolio.
The Exelon cut was one of several trims Heartland made across utility, energy, and real estate names. At the same time, the firm sharply increased its bet on industrial manufacturer Columbus McKinnon, raising that stake by 26.1%.
Heartland Cuts Utilities and Real Estate While Others Buy
Beyond Exelon, Heartland sold down Sensient Technologies by 7.3%, leaving it with 72,854 shares, according to Watchlist News. The firm also slashed its Alpine Income Property Trust position by 32.9% — its sharpest cut among the disclosed moves. NOV Inc. saw a smaller 3.2% reduction.
Other big institutions moved in the opposite direction on Exelon. Nordea Investment Management AB increased its Exelon holding by 14.6%, bringing its total to 8,048,355 shares. ASR Vermogensbeheer N.V. added even more aggressively, raising its stake 28.4% to 272,233 shares. The divergence shows that not all institutional investors read Exelon the same way right now.
Columbus McKinnon Draws a Wave of Institutional Buying
Heartland's 26.1% increase in Columbus McKinnon was far from a solo move. Marshall Wace LLP surged into the stock, growing its position by 698.6% to reach 726,772 shares. Hotchkis and Wiley Capital Management LLC doubled down too, raising its stake by 100.2% to 829,875 shares.
Institutional investors now own 95.96% of Columbus McKinnon's outstanding shares. That level of concentration means retail investors have almost no influence on the stock's price. When this many large funds pile in at once, it usually signals a shared conviction — in this case, a bet on industrial automation and infrastructure spending.
Sensient Insider Sells as Heartland Reduces Its Position
Heartland's Sensient Technologies trim coincided with an insider sale at the company. Vice President Thierry Hoang sold 439 shares at an average price of $114.15 per share, taking home about $50,111.85, according to Watchlist News. Insider sales don't always signal trouble, but the timing alongside Heartland's exit adds a note of caution.
Stifel Stays Bullish on NOV Despite Heartland's Small Trim
Heartland's 3.2% reduction in NOV did not shake analyst confidence in the energy services company. Stifel Nicolaus raised its price target on NOV from $21.00 to $23.00 and kept a "buy" rating on the stock. That upgrade came just days after Heartland filed its reduced position.
The gap between Heartland's cautious trim and Stifel's upgraded target points to a broader debate. Value-focused funds like Heartland may be locking in gains or rebalancing. Meanwhile, sell-side analysts see more upside ahead. Investors watching NOV are essentially getting two different signals at the same time.
Sentiment
Mostly PositivePublishers
32
Articles
22
Reach
54
